Jing Huang

Prof. Jing Huang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
CWChunbin Wang
Chunbin Wang
BXBo Xiong
Bo Xiong
JHJing Huang
Jing Huang

24 May 2016 in Respirology
Verified
Journal Article
Closed access
PDF file
BXBo Xiong
Bo Xiong
CWChunbin Wang
Chunbin Wang
JTJie Tan
Jie Tan
YCYin Cao
Yin Cao
YZYanke Zou
Yanke Zou
JHJing Huang
Jing Huang

31 August 2020 in Genes & Diseases
Verified
Journal Article
Open access
RWRuiyu Wang
Ruiyu Wang
YGYongzheng Guo
Yongzheng Guo
LLLingjiao Li
Lingjiao Li
MLMinghao Luo
Minghao Luo
LPLinqian Peng
Linqian Peng
JHJing Huang
Jing Huang
Excessive oxidative stress is a major causative factor of endothelial dysfunction in hypertension. As an endogenous pro-oxidant, thioredoxin-interacting protein (TXNIP) contributes to oxidative damage in various tissues. The present study aimed to investigate the role of TXNIP in mediating endothelial dysfunction in hypertension. In vivo, an experimental model of acquired hypertension was established with two-kidney, one-clip (2K1C) surgery. The expression of TXNIP in the vascular endothelial cells of multiple vessels was significantly increased in hypertensive rats compared with sham-operated rats. Resveratrol, a TXNIP inhibitor, suppressed vascular oxidative damage and increased the expression and activity of eNOS in the aorta of hypertensive rats. Notably, impaired endothelium-dependent vasodilation was effectively improved by TXNIP inhibition in hypertensive rats. In vitro, we observed that Ang II increased the expression of TXNIP in primary human aortic endothelial cells (HAECs) and that TXNIP knockdown by RNA interference alleviated cellular oxidative stress damage and mitigated the impaired eNOS activation and intracellular nitric oxide (NO) production observed in Ang II-treated HAECs. However, inhibiting thioredoxin (TRX) with PX-12 completely blunted the protective effect of silencing TXNIP. In addition, TXNIP knockdown facilitated TRX expression and promoted TRX nuclear translocation to further activate AP1 and REF1. TRX overexpression exhibited favorable effects on eNOS/NO homeostasis in Ang II-treated HAECs. Thus, TXNIP contributes to oxidative stress and endothelial dysfunction in hypertension, and these effects are dependent on the antioxidant capacity of TRX, suggesting that targeting TXNIP may be a novel strategy for antihypertensive therapy.

1 August 2019 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
YJYonghong Jiang
Yonghong Jiang
GYGang Yang
Gang Yang
QLQingyao Liao
Qingyao Liao
YZYanke Zou
Yanke Zou
YDYun Du
Yun Du
JHJing Huang
Jing Huang

1 October 2015 in Hypertension
Verified
Journal Article
Closed access
SRShunkang Rong
Shunkang Rong
HZHui Zhu
Hui Zhu
DLDichuan Liu
Dichuan Liu
JQJun Qian
Jun Qian
KZKun Zhou
Kun Zhou
JHJing Huang
Jing Huang

1 October 2013 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
SRShunkang Rong
Shunkang Rong
KWKamsang Woo
Kamsang Woo
QZQi Zhou
Qi Zhou
QZQue Zhu
Que Zhu
QWQi Wu
Qi Wu
JHJing Huang
Jing Huang